Olotadine Hydrochloride

盐酸奥洛他定

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameOlotadine Hydrochloride
Drug Alias Name盐酸奥洛帕定olopatadine奥洛他定Patanol ophthalmic solutionolopatadinum +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaConjunctivitis, AllergicRhinitis, Allergic, Seasonal +[5] 
Global Approved IndicationsUrticariaConjunctivitis, AllergicRhinitis, Allergic
Approved Indications in ChinaConjunctivitis, Allergic
Original Approved Country/TerritoryUnited States
Original Approved Date1996/12/18
Country/TerritoryCanadaUnited StatesEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAlcon Laboratories Inc
China Registration ClassN/A

Develop Information

Active CompaniesYingkerui (Hengqin) Pharmaceutical Research Institute Co LtdKyowa Hakko Kirin Co LtdNovartis Europharm Ltd +[4] 
Inactive CompaniesAlconNovartis Pharma AgAlcon (China) Ophthalmic Product Co Ltd +[4] 
Active IndicationsUrticariaConjunctivitis, AllergicRhinitis, Allergic
Inactive IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, Perennial

Other Information

ATC CodeR01AC08S01GX09
Related LinksWikipediaDrugBankKEGG